A pilot study examining mindfulness-based cognitive therapy in psoriasis

Psychology, Health and Medicine

Volumn 20, Issue 1, 2015, Pages 121-127

  Fordham, B ^a   Griffiths, C E M ^a   Bundy, C ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

mindfulness based cognitive therapy; psoriasis; stress

Indexed keywords

ADULT; AGED; COGNITIVE THERAPY; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MENTAL STRESS; MIDDLE AGED; MINDFULNESS; PILOT STUDY; PREVENTION AND CONTROL; PROCEDURES; PSORIASIS; PSYCHOLOGY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADULT; AGED; COGNITIVE THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; MINDFULNESS; PILOT PROJECTS; PSORIASIS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 84909969115     PISSN: 13548506     EISSN: None     Source Type: Journal    
DOI: 10.1080/13548506.2014.902483     Document Type: Article

References (25)

1. Altman, D., & Bland, J. (1999). Statistics notes: How to randomise. British Medical Journal, 319, 703-704.
2. Campbell, M., Fitzpatrick, R., Haines, A., Kinmonth, A., Sandercock, P., Spiegelhalter, D., & Tyrer, P. (2000). Framework for design and evaluation of complex interventions to improve health. British Medical Journal, 321, 694-696.
3. Carlin, C.S., Feldman, S.R., Krueger, J.G., Menter, A., & Krueger, G.G. (2004). A 50% reduction in the psoriasis area and severity index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis. Journal of the American Academy of Dermatology, 50, 859-866.
4. Cohen, S., Kamarck, T., & Mermelstein, R. (1983). A global measure of perceived stress. Journal of Health and Social Behavior, 24, 385-396.
5. Everitt, B. (2002). The Cambridge dictionary of statistic. (2nd ed.). Cambridge: CUP.
6. Feldman, S.R., Fleischer Jr., A.B., Reboussin, D.M., Rapp, S.R., Exum, M.L., Clark, A.R., & Nurre, L. (1996). The self-administered psoriasis area and severity index is valid and reliable. Journal of Investigative Dermatology, 106, 183-186.
7. Finlay, A.Y., & Kelly, S.E. (1987). Psoriasis-an index of disability. Clinical and Experimental Dermatology, 12, 8-11.
8. Fjorback, L.O., Arendt, M., Ørnbøl, E., Fink, P., & Walach, H. (2011). Mindfulness-based stress reduction and mindfulness-based cognitive therapy-A systematic review of randomized controlled trials. Acta Psychiatrica Scandinavica, 124, 102-119.
9. Fordham, B., Griffiths, C.E.M., & Bundy, C. (2012). Can stress reduction interventions improve psoriasis? A review. Psychology, Health & Medicine, 18, 501-514.
10. Grossman, P., Niemann, L., Schmidt, S., & Walach, H. (2004). Mindfulness-based stress reduction and health benefits. Journal of Psychosomatic Research, 57, 35-43.
11. Hayes, J., & Koo, J. (2010). Psoriasis: Depression, anxiety, smoking, and drinking habits. Dermatologic Therapy, 23, 174-180.
12. Khilji, F.A., Gonzalez, M., & Finlay, A.Y. (2002). Clinical meaning of change in dermatology life quality index scores. British Journal of Dermatology, 147, 50.
13. Koo, J.Y. (1995). Psychodermatology: A practical manual for clinicians. Current Problems in Dermatology, 7, 204-232.
14. Kurd, S.K., Troxel, A.B., Crits-Christoph, P., & Gelfand, J.M. (2010). The risk of depression, anxiety, and suicidality in patients with psoriasis: A population-based cohort study. Archives of Dermatology, 146, 891-895.
15. Lancaster, G., Dodd, S., & Williamson, P. (2002). Design and analysis of pilot studies: Recommendations for good practice. Journal of Evaluation in Clinical Practice, 10, 307-312.
16. Moss-Morris, R., Weinman, R., Petrie, K., Horne, R., Cameron, L., & Buick, D. (2002). The revised illness perceptions questionnaire. Psychology & Health, 17(1), 1-16.
17. O'Leary, C.J., Creamer, D., Higgins, E., & Weinman, J. (2004). Perceived stress, stress attributions and psychological distress in psoriasis. Journal of Psychosomatic Research, 57, 465-471.
18. Parisi, R., Symmons, D.P.M., Griffiths, C.E.M., & Ashcroft, D.M. (2013). Global epidemiology of psoriasis: A systematic review of incidence and prevalence. Journal of Investigative Dermatology, 133, 377-385.
19. Rapp, S.R., Feldman, S.R., Exum, M.L., Fleischer Jr., A.B., & Reboussin, D.M. (1999). Psoriasis causes as much disability as other major medical diseases. Journal of the American Academy of Dermatology, 41, 401-407.
20. Schmitt, J.M., & Ford, D. (2007). Role of depression in quality of life for patients with psoriasis. Dermatology, 215, 17-27.
21. Schmitt, J.M., & Wozel, G. (2005). The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis. Dermatology, 210, 194-199.
22. Segal, Z.V., Williams, M.G., & Teasdale, J.D. (2002). Mindfulness-based cognitive therapy for depression: A new approach to preventing relapse. New York, NY: The Guilford Press.
23. Williams, J.M. (2010). Mindfulness and psychological process. Emotion, 10(1), 1-7.
24. Witek-Janusek, L., Albuquerque, K., Chroniak, K.R., Chroniak, C., Durazo-Arvizu, R., & Mathews, H.L. (2008). Effect of mindfulness based stress reduction on immune function, quality of life and coping in women newly diagnosed with early stage breast cancer. Brain, Behavior, and Immunity, 22, 969-981.
25. Zigmond, A.S., & Snaith, R.P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67, 361-370.